<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>Genosera Inc. Latest Press Releases</title>
<link>https://pressroom.prlog.org/genosera/</link>
<description>About Genosera Inc. - Genosera, Inc. is a privately held gene therapy company. Genosera has developed a pipeline of proprietary innovative dual-gene AAV gene therapy treatments for rare neuromuscular and other genetic diseases. See www.genosera.com.</description>
<item><title>Genosera Inc. Plans Clinical Development with Novel Dual-gene Vector in Neuromuscular Diseases</title>
<link>https://www.prlog.org/13145090-genosera-inc-plans-clinical-development-with-novel-dual-gene-vector-in-neuromuscular-diseases.html</link>
<description>Genosera Inc. Exclusively Licenses Seven Novel IP Assets from Nationwide Children's Hospital, Readying for Gene Therapy Clinical Development</description><pubDate>Mon, 11 May 2026 21:36:54 GMT</pubDate></item>
</channel>
</rss>